Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Extremities Market by Product (Upper extremities, Lower extremities): Global Opportunity Analysis and Industry Forecast, 2023-2032

A01217

Pages: NA

Charts: NA

Tables: NA

Body extremities are extended organs mainly involved in locomotive functions. The human body has four extremities i.e. two upper limbs and two lower limbs. The extremities market is a small portion of the orthopedic industry. The joint reconstruction procedures involve modification of the body extremities. The human skeleton has more than 200 bones which are supported by tendons, ligaments and muscles. Hence, the prime focus of orthopedic industries was manufacture of devices and treatment procedures for joints, spine, knee and hip. But, now-a-days the focus of leading players on extremities market is increasing day by day as they offer better treatment options and provide growth opportunities to the key players.

The world extremities market is driven by the increase in the number of cases for orthopedic surgeons several factors such as increase in ageing population, awareness of the people for better treatment options and their expectations for a good quality of living. In addition, changes in the clinical practice patterns such as use of reversed shoulder instead of anatomic shoulder, use of arthroplasty procedure as an alternative to ankle fusion and increased use of implants in foot and ankle surgeries will also boost the market growth. Apart from this, development of new improved shoulders and ankles and need for less invasive devices will further propel the market growth. But the high unmet need for early diagnosis due to long waiting time in some countries is expected to hamper the market growth.

World extremities market is segmented on the basis of products and geography. Based on products, the market is segmented mainly into upper extremities and lower extremities. Upper extremities segment is further sub segmented into shoulder, elbow and hand & wrist. Lower extremities segment is further sub segmented into knee, hip and foot & ankle. The geographical classification includes North America, Europe, Asia-Pacific and LAMEA regions.

As the extremities market is in the expansion phase, mergers and acquisitions are frequent in this market. In October 2015 Wright Medical Group, Inc. and Tornier N.V merged together to form Wright Medical Group N.V. This has helped the company to establish themselves as the premier, high-growth extremities-biologics company and extend its leadership position and further accelerate its growth opportunities.
Key players in this market include DePuy Synthes (a wholly owned subsidiary of Johnson & Johnson), Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew plc, Integra Lifesciences Holdings Corporation, Wright Medical Group N.V., Exactech, Inc., Arthrex, Inc., CONMED Corporation and Skeletal Dynamics LLC.

KEY MARKET BENEFITS:

  • The study provides an in-depth analysis of the world extremities market with current trends and future estimations to elucidate the imminent investment pockets.
  • The report provides a quantitative analysis which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Extensive analysis by product helps in understanding the various types of devices used.
  • Competitive intelligence highlights the business practices followed by leading players across various regions.
  • Comprehensive analysis of all geographic regions are provided that helps in determining the prevailing opportunities in these geographies
  • Key market players within the world extremities market are profiled in the report and their strategies are analysed thoroughly, which helps in understanding competitive outlook of the global market
  • Extensive analysis of the market is conducted by closely following key product positioning and monitoring the top contenders within the market framework

Key Market Segments

  • By Product
    • Upper extremities
      • Shoulder
      • Elbow
      • Hand & wrist
    • Lower extremities
      • Hip
      • Knee
      • Foot & ankle
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Egypt
      • Rest of LAMEA


Key Market Players

  • Arthrex, Inc.
  • Integra Lifesciences Holdings Corporation
  • Wright Medical Group N.V.
  • Smith & Nephew plc
  • Skeletal Dynamics LLC.
  • Zimmer Biomet Holdings, Inc.
  • Exactech, Inc.
  • DePuy Synthes (a wholly owned subsidiary of Johnson & Johnson)
  • Stryker Corporation
  • CONMED Corporation
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: EXTREMITIES MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Upper Extremities

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

      • 4.2.4. Shoulder

        • 4.2.4.1. Market Size and Forecast
      • 4.2.4. Elbow

        • 4.2.4.1. Market Size and Forecast
      • 4.2.4. Hand and wrist

        • 4.2.4.1. Market Size and Forecast
    • 4.3. Lower Extremities

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

      • 4.3.4. Hip

        • 4.3.4.1. Market Size and Forecast
      • 4.3.4. Knee

        • 4.3.4.1. Market Size and Forecast
      • 4.3.4. Foot and ankle

        • 4.3.4.1. Market Size and Forecast
  • CHAPTER 5: EXTREMITIES MARKET, BY REGION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Region

    • 5.2. North America

      • 5.2.1. Key Market Trends and Opportunities

      • 5.2.2. Market Size and Forecast, By Product

      • 5.2.3. Market Size and Forecast, By Country

      • 5.2.4. U.S. Extremities Market

        • 5.2.4.1. Market Size and Forecast, By Product
      • 5.2.5. Canada Extremities Market

        • 5.2.5.1. Market Size and Forecast, By Product
      • 5.2.6. Mexico Extremities Market

        • 5.2.6.1. Market Size and Forecast, By Product
    • 5.3. Europe

      • 5.3.1. Key Market Trends and Opportunities

      • 5.3.2. Market Size and Forecast, By Product

      • 5.3.3. Market Size and Forecast, By Country

      • 5.3.4. France Extremities Market

        • 5.3.4.1. Market Size and Forecast, By Product
      • 5.3.5. Germany Extremities Market

        • 5.3.5.1. Market Size and Forecast, By Product
      • 5.3.6. Italy Extremities Market

        • 5.3.6.1. Market Size and Forecast, By Product
      • 5.3.7. Spain Extremities Market

        • 5.3.7.1. Market Size and Forecast, By Product
      • 5.3.8. UK Extremities Market

        • 5.3.8.1. Market Size and Forecast, By Product
      • 5.3.9. Russia Extremities Market

        • 5.3.9.1. Market Size and Forecast, By Product
      • 5.3.10. Rest Of Europe Extremities Market

        • 5.3.10.1. Market Size and Forecast, By Product
    • 5.4. Asia-Pacific

      • 5.4.1. Key Market Trends and Opportunities

      • 5.4.2. Market Size and Forecast, By Product

      • 5.4.3. Market Size and Forecast, By Country

      • 5.4.4. China Extremities Market

        • 5.4.4.1. Market Size and Forecast, By Product
      • 5.4.5. Japan Extremities Market

        • 5.4.5.1. Market Size and Forecast, By Product
      • 5.4.6. India Extremities Market

        • 5.4.6.1. Market Size and Forecast, By Product
      • 5.4.7. South Korea Extremities Market

        • 5.4.7.1. Market Size and Forecast, By Product
      • 5.4.8. Australia Extremities Market

        • 5.4.8.1. Market Size and Forecast, By Product
      • 5.4.9. Thailand Extremities Market

        • 5.4.9.1. Market Size and Forecast, By Product
      • 5.4.10. Malaysia Extremities Market

        • 5.4.10.1. Market Size and Forecast, By Product
      • 5.4.11. Indonesia Extremities Market

        • 5.4.11.1. Market Size and Forecast, By Product
      • 5.4.12. Rest of Asia Pacific Extremities Market

        • 5.4.12.1. Market Size and Forecast, By Product
    • 5.5. LAMEA

      • 5.5.1. Key Market Trends and Opportunities

      • 5.5.2. Market Size and Forecast, By Product

      • 5.5.3. Market Size and Forecast, By Country

      • 5.5.4. Brazil Extremities Market

        • 5.5.4.1. Market Size and Forecast, By Product
      • 5.5.5. South Africa Extremities Market

        • 5.5.5.1. Market Size and Forecast, By Product
      • 5.5.6. Saudi Arabia Extremities Market

        • 5.5.6.1. Market Size and Forecast, By Product
      • 5.5.7. UAE Extremities Market

        • 5.5.7.1. Market Size and Forecast, By Product
      • 5.5.8. Argentina Extremities Market

        • 5.5.8.1. Market Size and Forecast, By Product
      • 5.5.9. Rest of LAMEA Extremities Market

        • 5.5.9.1. Market Size and Forecast, By Product
  • CHAPTER 6: COMPETITIVE LANDSCAPE

    • 6.1. Introduction

    • 6.2. Top Winning Strategies

    • 6.3. Product Mapping Of Top 10 Player

    • 6.4. Competitive Dashboard

    • 6.5. Competitive Heatmap

    • 6.6. Top Player Positioning, 2024

  • CHAPTER 7: COMPANY PROFILES

    • 7.1. DePuy Synthes (a Wholly Owned Subsidiary Of Johnson And Johnson)

      • 7.1.1. Company Overview

      • 7.1.2. Key Executives

      • 7.1.3. Company Snapshot

      • 7.1.4. Operating Business Segments

      • 7.1.5. Product Portfolio

      • 7.1.6. Business Performance

      • 7.1.7. Key Strategic Moves and Developments

    • 7.2. Stryker Corporation

      • 7.2.1. Company Overview

      • 7.2.2. Key Executives

      • 7.2.3. Company Snapshot

      • 7.2.4. Operating Business Segments

      • 7.2.5. Product Portfolio

      • 7.2.6. Business Performance

      • 7.2.7. Key Strategic Moves and Developments

    • 7.3. Zimmer Biomet Holdings, Inc.

      • 7.3.1. Company Overview

      • 7.3.2. Key Executives

      • 7.3.3. Company Snapshot

      • 7.3.4. Operating Business Segments

      • 7.3.5. Product Portfolio

      • 7.3.6. Business Performance

      • 7.3.7. Key Strategic Moves and Developments

    • 7.4. Smith And Nephew Plc

      • 7.4.1. Company Overview

      • 7.4.2. Key Executives

      • 7.4.3. Company Snapshot

      • 7.4.4. Operating Business Segments

      • 7.4.5. Product Portfolio

      • 7.4.6. Business Performance

      • 7.4.7. Key Strategic Moves and Developments

    • 7.5. Integra Lifesciences Holdings Corporation

      • 7.5.1. Company Overview

      • 7.5.2. Key Executives

      • 7.5.3. Company Snapshot

      • 7.5.4. Operating Business Segments

      • 7.5.5. Product Portfolio

      • 7.5.6. Business Performance

      • 7.5.7. Key Strategic Moves and Developments

    • 7.6. Wright Medical Group N.V.

      • 7.6.1. Company Overview

      • 7.6.2. Key Executives

      • 7.6.3. Company Snapshot

      • 7.6.4. Operating Business Segments

      • 7.6.5. Product Portfolio

      • 7.6.6. Business Performance

      • 7.6.7. Key Strategic Moves and Developments

    • 7.7. Exactech, Inc.

      • 7.7.1. Company Overview

      • 7.7.2. Key Executives

      • 7.7.3. Company Snapshot

      • 7.7.4. Operating Business Segments

      • 7.7.5. Product Portfolio

      • 7.7.6. Business Performance

      • 7.7.7. Key Strategic Moves and Developments

    • 7.8. Arthrex, Inc.

      • 7.8.1. Company Overview

      • 7.8.2. Key Executives

      • 7.8.3. Company Snapshot

      • 7.8.4. Operating Business Segments

      • 7.8.5. Product Portfolio

      • 7.8.6. Business Performance

      • 7.8.7. Key Strategic Moves and Developments

    • 7.9. CONMED Corporation

      • 7.9.1. Company Overview

      • 7.9.2. Key Executives

      • 7.9.3. Company Snapshot

      • 7.9.4. Operating Business Segments

      • 7.9.5. Product Portfolio

      • 7.9.6. Business Performance

      • 7.9.7. Key Strategic Moves and Developments

    • 7.10. Skeletal Dynamics LLC.

      • 7.10.1. Company Overview

      • 7.10.2. Key Executives

      • 7.10.3. Company Snapshot

      • 7.10.4. Operating Business Segments

      • 7.10.5. Product Portfolio

      • 7.10.6. Business Performance

      • 7.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL EXTREMITIES MARKET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL EXTREMITIES MARKET FOR UPPER EXTREMITIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL EXTREMITIES MARKET FOR LOWER EXTREMITIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL EXTREMITIES MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. NORTH AMERICA EXTREMITIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. NORTH AMERICA EXTREMITIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 7. U.S. EXTREMITIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 8. CANADA EXTREMITIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 9. MEXICO EXTREMITIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 10. EUROPE EXTREMITIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. EUROPE EXTREMITIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 12. FRANCE EXTREMITIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 13. GERMANY EXTREMITIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 14. ITALY EXTREMITIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 15. SPAIN EXTREMITIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 16. UK EXTREMITIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 17. RUSSIA EXTREMITIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 18. REST OF EUROPE EXTREMITIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 19. ASIA-PACIFIC EXTREMITIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 20. ASIA-PACIFIC EXTREMITIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 21. CHINA EXTREMITIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 22. JAPAN EXTREMITIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 23. INDIA EXTREMITIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 24. SOUTH KOREA EXTREMITIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 25. AUSTRALIA EXTREMITIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 26. THAILAND EXTREMITIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 27. MALAYSIA EXTREMITIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 28. INDONESIA EXTREMITIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 29. REST OF ASIA PACIFIC EXTREMITIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 30. LAMEA EXTREMITIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 31. LAMEA EXTREMITIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 32. BRAZIL EXTREMITIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 33. SOUTH AFRICA EXTREMITIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 34. SAUDI ARABIA EXTREMITIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 35. UAE EXTREMITIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 36. ARGENTINA EXTREMITIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 37. REST OF LAMEA EXTREMITIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 38. DEPUY SYNTHES (A WHOLLY OWNED SUBSIDIARY OF JOHNSON AND JOHNSON): KEY EXECUTIVES
  • TABLE 39. DEPUY SYNTHES (A WHOLLY OWNED SUBSIDIARY OF JOHNSON AND JOHNSON): COMPANY SNAPSHOT
  • TABLE 40. DEPUY SYNTHES (A WHOLLY OWNED SUBSIDIARY OF JOHNSON AND JOHNSON): OPERATING SEGMENTS
  • TABLE 41. DEPUY SYNTHES (A WHOLLY OWNED SUBSIDIARY OF JOHNSON AND JOHNSON): PRODUCT PORTFOLIO
  • TABLE 42. DEPUY SYNTHES (A WHOLLY OWNED SUBSIDIARY OF JOHNSON AND JOHNSON): KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 43. STRYKER CORPORATION: KEY EXECUTIVES
  • TABLE 44. STRYKER CORPORATION: COMPANY SNAPSHOT
  • TABLE 45. STRYKER CORPORATION: OPERATING SEGMENTS
  • TABLE 46. STRYKER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 47. STRYKER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 48. ZIMMER BIOMET HOLDINGS, INC.: KEY EXECUTIVES
  • TABLE 49. ZIMMER BIOMET HOLDINGS, INC.: COMPANY SNAPSHOT
  • TABLE 50. ZIMMER BIOMET HOLDINGS, INC.: OPERATING SEGMENTS
  • TABLE 51. ZIMMER BIOMET HOLDINGS, INC.: PRODUCT PORTFOLIO
  • TABLE 52. ZIMMER BIOMET HOLDINGS, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 53. SMITH AND NEPHEW PLC: KEY EXECUTIVES
  • TABLE 54. SMITH AND NEPHEW PLC: COMPANY SNAPSHOT
  • TABLE 55. SMITH AND NEPHEW PLC: OPERATING SEGMENTS
  • TABLE 56. SMITH AND NEPHEW PLC: PRODUCT PORTFOLIO
  • TABLE 57. SMITH AND NEPHEW PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 58. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: KEY EXECUTIVES
  • TABLE 59. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT
  • TABLE 60. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: OPERATING SEGMENTS
  • TABLE 61. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 62. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 63. WRIGHT MEDICAL GROUP N.V.: KEY EXECUTIVES
  • TABLE 64. WRIGHT MEDICAL GROUP N.V.: COMPANY SNAPSHOT
  • TABLE 65. WRIGHT MEDICAL GROUP N.V.: OPERATING SEGMENTS
  • TABLE 66. WRIGHT MEDICAL GROUP N.V.: PRODUCT PORTFOLIO
  • TABLE 67. WRIGHT MEDICAL GROUP N.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 68. EXACTECH, INC.: KEY EXECUTIVES
  • TABLE 69. EXACTECH, INC.: COMPANY SNAPSHOT
  • TABLE 70. EXACTECH, INC.: OPERATING SEGMENTS
  • TABLE 71. EXACTECH, INC.: PRODUCT PORTFOLIO
  • TABLE 72. EXACTECH, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 73. ARTHREX, INC.: KEY EXECUTIVES
  • TABLE 74. ARTHREX, INC.: COMPANY SNAPSHOT
  • TABLE 75. ARTHREX, INC.: OPERATING SEGMENTS
  • TABLE 76. ARTHREX, INC.: PRODUCT PORTFOLIO
  • TABLE 77. ARTHREX, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 78. CONMED CORPORATION: KEY EXECUTIVES
  • TABLE 79. CONMED CORPORATION: COMPANY SNAPSHOT
  • TABLE 80. CONMED CORPORATION: OPERATING SEGMENTS
  • TABLE 81. CONMED CORPORATION: PRODUCT PORTFOLIO
  • TABLE 82. CONMED CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 83. SKELETAL DYNAMICS LLC.: KEY EXECUTIVES
  • TABLE 84. SKELETAL DYNAMICS LLC.: COMPANY SNAPSHOT
  • TABLE 85. SKELETAL DYNAMICS LLC.: OPERATING SEGMENTS
  • TABLE 86. SKELETAL DYNAMICS LLC.: PRODUCT PORTFOLIO
  • TABLE 87. SKELETAL DYNAMICS LLC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL EXTREMITIES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL EXTREMITIES MARKET
  • FIGURE 3. SEGMENTATION EXTREMITIES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN EXTREMITIES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALEXTREMITIES MARKET
  • FIGURE 11. EXTREMITIES MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. EXTREMITIES MARKET FOR UPPER EXTREMITIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. EXTREMITIES MARKET FOR LOWER EXTREMITIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 15. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 16. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 17. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 18. COMPETITIVE DASHBOARD
  • FIGURE 19. COMPETITIVE HEATMAP: EXTREMITIES MARKET
  • FIGURE 20. TOP PLAYER POSITIONING, 2024
  • FIGURE 21. DEPUY SYNTHES (A WHOLLY OWNED SUBSIDIARY OF JOHNSON AND JOHNSON): NET SALES, 2022-2024 ($MILLION)
  • FIGURE 22. DEPUY SYNTHES (A WHOLLY OWNED SUBSIDIARY OF JOHNSON AND JOHNSON): REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 23. DEPUY SYNTHES (A WHOLLY OWNED SUBSIDIARY OF JOHNSON AND JOHNSON): REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 24. STRYKER CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 25. STRYKER CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 26. STRYKER CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 27. ZIMMER BIOMET HOLDINGS, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 28. ZIMMER BIOMET HOLDINGS, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 29. ZIMMER BIOMET HOLDINGS, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 30. SMITH AND NEPHEW PLC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 31. SMITH AND NEPHEW PLC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 32. SMITH AND NEPHEW PLC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 33. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 34. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 35. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 36. WRIGHT MEDICAL GROUP N.V.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 37. WRIGHT MEDICAL GROUP N.V.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 38. WRIGHT MEDICAL GROUP N.V.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 39. EXACTECH, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 40. EXACTECH, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 41. EXACTECH, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 42. ARTHREX, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 43. ARTHREX, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 44. ARTHREX, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 45. CONMED CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 46. CONMED CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 47. CONMED CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 48. SKELETAL DYNAMICS LLC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 49. SKELETAL DYNAMICS LLC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 50. SKELETAL DYNAMICS LLC.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Extremities Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue